ImmunoGen (NASDAQ:IMGN) reported Q4 2017 earnings this Morning, coming in at ($0.11) per share, missing Wall Street’s estimates of ($0.10) per Share. Revenue for the quarter came in at $39.40 million missing the streets estimates of $39.62 million Recent Insider Trading for ImmunoGen (NASDAQ:IMGN)
- On 1/8/2018 Richard J Gregory, VP, sold 2,904 with an average share price of $6.64 per share and the total transaction amounting to $19,282.56.
- On 9/15/2017 Craig Barrows, VP, sold 37,050 with an average share price of $6.81 per share and the total transaction amounting to $252,310.50.
- On 9/13/2017 Craig Barrows, VP, sold 14,600 with an average share price of $6.95 per share and the total transaction amounting to $101,470.00.
- On 12/15/2016 Mark Alan Goldberg, Director, bought 20,000 with an average share price of $1.80 per share and the total transaction amounting to $36,000.00.
- On 11/8/2016 Mark J Enyedy, CEO, bought 25,000 with an average share price of $1.83 per share and the total transaction amounting to $45,750.00.
- On 11/2/2016 Craig Barrows, Insider, bought 10,000 with an average share price of $1.71 per share and the total transaction amounting to $17,100.00.
Recent Trading for ImmunoGen (NASDAQ:IMGN) Shares of ImmunoGen closed the previous trading session at 8.43 down -0.33 3.77% with shares trading hands.